Invention Grant
- Patent Title: Direct visualization system for glaucoma treatment
-
Application No.: US13865927Application Date: 2013-04-18
-
Publication No.: US10085633B2Publication Date: 2018-10-02
- Inventor: Michael Schaller , Tsontcho Ianchulev , Richard S. Lilly , Luke Clauson , David Lari
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61B3/10
- IPC: A61B3/10 ; A61B90/00 ; A61F9/007 ; A61F9/008 ; A61F9/00

Abstract:
A direct visualization (DV) system and methods are disclosed for measuring one or more anatomical features of the eye, including a depth of the iridocorneal angle of the eye. The DV system can include a wire extending distally from a handle with the wire having one or more indicators for measuring anatomical features of the eye. The DV system can be deployed into the eye and used with minimal trauma to ocular tissues. Furthermore, the DV system can be used independently or alongside other ocular instruments, such as instruments having indicators corresponding to the DV system for correctly implanting ocular implants without the use of a gonio lens.
Public/Granted literature
- US20130281817A1 DIRECT VISUALIZATION SYSTEM FOR GLAUCOMA TREATMENT Public/Granted day:2013-10-24
Information query